Comparative Pharmacokinetics of AFOLIA and US Gonal-f RFF Redi-ject After Single Subcutaneous Application. A Randomised, Open Label, 2-way Cross-over Study

Trial Profile

Comparative Pharmacokinetics of AFOLIA and US Gonal-f RFF Redi-ject After Single Subcutaneous Application. A Randomised, Open Label, 2-way Cross-over Study

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Feb 2017

At a glance

  • Drugs Follitropin alfa (Primary)
  • Indications Female infertility
  • Focus Pharmacokinetics
  • Sponsors Fertility Biotech
  • Most Recent Events

    • 17 Feb 2017 Status changed from recruiting to completed.
    • 04 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top